🇺🇸 FDA
Patent

US 8518957

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

granted A61PA61P21/00A61P27/00

Quick answer

US patent 8518957 (Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P21/00, A61P27/00, A61P27/02, A61P35/00